Back to search

University of Glasgow

Thromboxane Biosynthesis and its Inhibition in Man

Abstract

dc:description.abstract

The principal product of arachidonic acid in the platelet is thromboxane A2 This compound is the most potent endogenous platelet agonist and vasoconstrictor known in man. Thromboxane A has been implicated in diverse human diseases in which platelet activation and vasospasm are known to occur. There has therefore been considerable interest in the development of therapeutic regimens designed to inhibit thromboxane biosynthesis. The studies described in this thesis investigated endogenous formation of thromboxane in human syndromes of platelet activation and examined the biochemical and functional effects of different approaches to inhibition of thromboxane production in health and disease.

Degree

thesis:*
Level dc:type.qualificationlevel
MD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1987

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Reilly, Irene A. G

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Reilly, Irene A. G. Thromboxane Biosynthesis and its Inhibition in Man. MD thesis, University of Glasgow, 1987.